The optional approach of oncogene-addicted non-small cell lung cancer with brain metastases in the new generation targeted therapies era

Tekijä Spagnuolo, Alessia, Muto, Matteo, Monaco, Fabio, Colantuoni, Giuseppe, Gridelli, Cesare
Julkaisussa Transl Lung Cancer Res (2019)

Exemestane and Everolimus combination treatment of hormone receptor positive, HER2 negative metastatic breast cancer: A retrospective study of 9 cancer centers in the Campania Regi...

Tekijä Riccardi, Ferdinando, Colantuoni, Giuseppe, Diana, Anna, Mocerino, Carmela, Cartenì, Giacomo, Lauria, Rossella, Febbraro, Antonio, Nuzzo, Francesco, Addeo, Raffaele, Marano, Ombretta, Incoronato, Pasquale, De Placido, Sabino, Ciardiello, Fortunato, Orditura, Michele
Julkaisussa Mol Clin Oncol (2018)

Second line trastuzumab emtansine following horizontal dual blockade in a real-life setting

Tekijä Prete, Salvatore Del, Montella, Liliana, Arpino, Grazia, Buono, Giuseppe, Buonerba, Carlo, Dolce, Pasquale, Fiorentino, Olga, Aliberti, Maria, Febbraro, Antonio, Savastano, Clementina, Colantuoni, Giuseppe, Riccardi, Ferdinando, Ruggiero, Angela, Placido, Sabino De, Orditura, Michele
Julkaisussa Oncotarget (2020)

Composite risk and benefit from adjuvant dose-dense chemotherapy in hormone receptor-positive breast cancer

Tekijä Puglisi, Fabio, Gerratana, Lorenzo, Lambertini, Matteo, Ceppi, Marcello, Boni, Luca, Montemurro, Filippo, Russo, Stefania, Bighin, Claudia, De Laurentiis, Michelino, Giuliano, Mario, Bisagni, Giancarlo, Durando, Antonio, Turletti, Anna, Garrone, Ornella, Ardizzoni, Andrea, Gamucci, Teresa, Colantuoni, Giuseppe, Gravina, Adriano, De Placido, Sabino, Cognetti, Francesco, Del Mastro, Lucia
Julkaisussa NPJ Breast Cancer (2021)